| 919 |
875: Binding of agonist, Ionotropic glutamate receptors |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 921 |
898: Disruption, Lysosome |
209: Peptide Oxidation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 922 |
209: Peptide Oxidation |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 942 |
913: Activation, Epidermal Growth Factor Receptor |
919: Occurrence, Transdifferentiation of ciliated epithelial cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 948 |
209: Peptide Oxidation |
926: Oxidation, Glutathione |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 989 |
921: Goblet cell hyperplasia |
943: Hypersecretion, Mucus |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 990 |
920: Goblet cell metaplasia |
943: Hypersecretion, Mucus |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 991 |
962: Increase, Mucin production |
943: Hypersecretion, Mucus |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 994 |
87: Release, Cytokine |
901: Infiltration, Inflammatory cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1271 |
1215: TRPA1 activation, TRPA1 Receptor |
1218: Opening of calcium channel, Calcium influx |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 1279 |
1222: SP (Substance P) release, Local increase of SP |
1224: Non-neuronal production of TNF, Epithelial irritation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1280 |
1218: Opening of calcium channel, Calcium influx |
1222: SP (Substance P) release, Local increase of SP |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1281 |
1230: TRPV1 activation, TRPV1 |
1218: Opening of calcium channel, Calcium influx |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 129 |
112: Antagonism, Estrogen receptor |
285: Reduction, Vitellogenin synthesis in liver |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 45 |
36: Inhibition, Aromatase |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 346 |
376: Increased, Induced Mutations in Critical Genes |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 888 |
868: Increase, Tissue Degeneration, Necrosis & Atrophy |
869: Increase, Respiratory or Squamous Metaplasia |
Nov 29, 2016 |
Dec 1, 2016 |
1 AOP
|
| 889 |
869: Increase, Respiratory or Squamous Metaplasia |
870: Increase, Cell Proliferation |
Nov 29, 2016 |
Dec 1, 2016 |
1 AOP
|
| 894 |
876: Increase, Mutations in Critical Genes |
872: Increase, Site of Contact Nasal Tumors |
Nov 29, 2016 |
Dec 1, 2016 |
1 AOP
|
| 895 |
870: Increase, Cell Proliferation |
872: Increase, Site of Contact Nasal Tumors |
Nov 29, 2016 |
Dec 1, 2016 |
1 AOP
|
| 369 |
227: Activation, PPARα |
266: Decrease, Steroidogenic acute regulatory protein (STAR) |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 370 |
227: Activation, PPARα |
289: Decrease, Translocator protein (TSPO) |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 437 |
289: Decrease, Translocator protein (TSPO) |
447: Reduction, Cholesterol transport in mitochondria |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 438 |
447: Reduction, Cholesterol transport in mitochondria |
413: Reduction, Testosterone synthesis in Leydig cells |
Nov 29, 2016 |
Dec 2, 2016 |
2 AOPs
|
| 439 |
413: Reduction, Testosterone synthesis in Leydig cells |
446: Reduction of testosterone |
Nov 29, 2016 |
Dec 2, 2016 |
None
|